Skip to main content
. Author manuscript; available in PMC: 2010 Nov 24.
Published in final edited form as: J Am Coll Surg. 1998 Oct;187(4):358–364. doi: 10.1016/s1072-7515(98)00207-5

Table 5.

Characteristics of 5-year survivors

Patient no. Age (y) Gender Operation pTNM Stage Adjuvant therapy Result
1 40 Male OLT-CL IV-B(T3, NO, M1) None Alive, free of tumor, >8 y
2 43 Male OLT I(T1, NO, MO) Preop. radiation Alive, free of tumor, >15 y
3 24 Female OLT II (T2, NO, MO) Preop. radiation Alive, free of tumor, > 11 y
4 38 Male OLT II (T2, NO, MO) Postop. radiation Died with tumor, 8 y, 3 mo
5 51 Male OLT II (T2, NO, MO) Preop. radiation Alive, free of tumor, >7 y
6 47 Female OLT II (T2, NO, MO) Preop. radiation Alive, free of tumor, >7 y
7 35 Male OLT II (T2, NO, MO) Postop. radiation Alive, free of tumor, >7 y
8 52 Male OLT II (T2, NO, MO) None Alive, free of tumor, >6 y
9 44 Female Hx (RTS) IV-A (T3, NO, MO) Postop. radiation Died with tumor, 8 y, 9 mo
10 32 Female Hx (RTS) II (T2, NO, MO) Postop. radiation Alive, free of tumor, >5 y

Hx, hepatic resection; OLT, orthotopic liver transplantation; OLT-CL, cluster liver transplantation; Preop., preoperative; Postop., postoperative; RTS, right trisegmentectomy.